I just spoke with Hemispherx. Please note that this information is completely preliminary, but the clinical trial team told me they're trying to extend its compassionate care program so more patients can have access to the drug for longer period of time at no-cost or low-cost (not sure). Of course, this isn't the first time such promises have been made (if you look at the checkered history of the drug), but I hope this time will be different. If anything, today gives me the perfect alibi to go out on a limb and say "this time things will be different." Realistically, looking at their financial statements, I'm not sure how they can do a compassionate care program unless they have XMRV-related grants coming in and are being assured the results of their phase III study will be better-received by the FDA this time around. From our conversation, it does sound like certain established CFS physicians will be involved in the upcoming renewed phase III clinical trial, but the open-label study where you will be sure to get the drug at cost is also going to stay open. I certainly can't afford to take the drug at cost forever as my treatment in Columbus really dried out our funds, but my sincere hope is that the landscape for CFS treatment will be dramatically different by next year.